Jeff Cislini, the General Counsel of $RVMD, sold 1,799 shares of the company on 09-24-2025 for an estimated $79,623. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4% of their shares of this class of stock. Following this trade, they now own 50,425 shares of this class of $RVMD stock.
$RVMD Insider Trading Activity
$RVMD insiders have traded $RVMD stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $RVMD stock by insiders over the last 6 months:
- STEPHEN MICHAEL KELSEY (See Remarks) has made 0 purchases and 6 sales selling 134,656 shares for an estimated $5,974,527.
- MARK A GOLDSMITH (See Remarks) has made 0 purchases and 2 sales selling 26,907 shares for an estimated $1,152,103.
- JACK ANDERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 14,490 shares for an estimated $593,737.
- MARGARET A HORN (Chief Operating Officer) has made 0 purchases and 2 sales selling 8,285 shares for an estimated $358,617.
- JEFF CISLINI (General Counsel) has made 0 purchases and 4 sales selling 7,458 shares for an estimated $315,807.
- LIN WEI (Chief Medical Officer) has made 0 purchases and 2 sales selling 4,333 shares for an estimated $185,532.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RVMD Hedge Fund Activity
We have seen 161 institutional investors add shares of $RVMD stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 6,030,999 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $221,880,453
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,015,869 shares (+180.2%) to their portfolio in Q2 2025, for an estimated $110,953,820
- DEERFIELD MANAGEMENT COMPANY, L.P. added 2,492,485 shares (+279.6%) to their portfolio in Q2 2025, for an estimated $91,698,523
- WELLINGTON MANAGEMENT GROUP LLP removed 1,528,183 shares (-13.0%) from their portfolio in Q2 2025, for an estimated $56,221,852
- BAKER BROS. ADVISORS LP added 1,428,000 shares (+18.0%) to their portfolio in Q2 2025, for an estimated $52,536,120
- CITADEL ADVISORS LLC added 1,344,608 shares (+1010.5%) to their portfolio in Q2 2025, for an estimated $49,468,128
- BALYASNY ASSET MANAGEMENT L.P. removed 1,302,848 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $46,068,705
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RVMD Analyst Ratings
Wall Street analysts have issued reports on $RVMD in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 09/12/2025
- Needham issued a "Buy" rating on 09/11/2025
- Wells Fargo issued a "Overweight" rating on 09/11/2025
- Wedbush issued a "Outperform" rating on 09/11/2025
- Piper Sandler issued a "Overweight" rating on 08/19/2025
- Guggenheim issued a "Buy" rating on 06/25/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for $RVMD, check out Quiver Quantitative's $RVMD forecast page.
$RVMD Price Targets
Multiple analysts have issued price targets for $RVMD recently. We have seen 13 analysts offer price targets for $RVMD in the last 6 months, with a median target of $73.0.
Here are some recent targets:
- Andrea Newkirk from Goldman Sachs set a target price of $73.0 on 09/12/2025
- Sean McCutcheon from Raymond James set a target price of $72.0 on 09/12/2025
- Robert Driscoll from Wedbush set a target price of $77.0 on 09/11/2025
- Ami Fadia from Needham set a target price of $66.0 on 09/11/2025
- Eva Fortea Verdejo from Wells Fargo set a target price of $70.0 on 09/11/2025
- Asthika Goonewardene from Truist Securities set a target price of $99.0 on 09/05/2025
- Kelsey Goodwin from Piper Sandler set a target price of $75.0 on 08/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
